Fred Hutchinson Cancer Research Center
- Assets
- $1.7b
- Revenue
- $943.4m
- Investments
- $35.2m
- Employees
- 3,721
- Location
- Seattle, WA
- Founding
- 05/1972
- Data as of
- 06/2021
- EIN
- 23-7156071
Organization Overview
Fred Hutchinson Cancer Research Center is located in Seattle, WA. The organization was established in 1972. According to its NTEE Classification (H30) the organization is classified as: Cancer Research, under the broad grouping of Medical Research and related organizations. As of 03/2022, Fred Hutchinson Cancer Research Center employed 3,721 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Fred Hutchinson Cancer Research Center is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2021, Fred Hutchinson Cancer Research Center generated $943.4m in total revenue. This represents relatively stable growth, over the past 6 years the organization has increased revenue by an average of 7.9% each year. All expenses for the organization totaled $829.7m during the year ending 06/2021. While expenses have increased by 9.5% per year over the past 6 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2015, Fred Hutchinson Cancer Research Center has awarded 2,224 individual grants totaling $703,873,872. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
FRED HUTCHINSON CANCER RESEARCH CENTER (FRED HUTCH) IS ON THE VANGUARD OF SCIENTIFIC RESEARCH IN CANCER AND HIV - DRIVING DISCOVERY TO MAKE THE WORLD A BETTER PLACE.
Describe the Organization's Program Activity:
Part 3 - Line 4a
VACCINE AND INFECTIOUS DISEASE DIVISION (VIDD): VIDD INTEGRATES THE LATEST IN COMPUTATIONAL, LABORATORY AND CLINICAL RESEARCH METHODS TO ADVANCE THE UNDERSTANDING OF MICROBIAL PATHOGENESIS AND INFECTIOUS DISEASE PROCESSES. VIDD RESEARCHERS PARTNER WITH SCIENTISTS AT LABORATORY, CLINICAL AND FIELD SITES IN THE AMERICAS, AFRICA, ASIA AND EUROPE. THE DIVISION HAS SPECIFIC INITIATIVES IN UGANDA, CHINA AND THE REPUBLIC OF SOUTH AFRICA TO ADVANCE THE UNDERSTANDING OF INFECTION-RELATED CANCERS AND INFECTIOUS DISEASES THAT AFFECT HIGH-RISK POPULATIONS IN THESE REGIONS. VIDD SCIENTISTS AROUND THE WORLD, INCLUDING CLINICIANS, CLINICAL TRIAL SPECIALISTS, STATISTICIANS, COMPUTATIONAL BIOLOGISTS AND BASIC SCIENTISTS, TAKE PRIDE IN THEIR COLLABORATIVE EFFORTS TO PREDICT, DETECT, TREAT AND PREVENT INFECTIOUS DISEASES IN HUMANS, INCLUDING KNOWN AND EMERGING INFECTIONS OF MAJOR GLOBAL HEALTH IMPORTANCE, SUCH AS CORONAVIRUS, AND CANCER-RELATED INFECTIOUS DISEASES.
CLINICAL RESEARCH DIVISION:THE CLINICAL RESEARCH DIVISION CONDUCTS LABORATORY AND PATIENT-ORIENTED RESEARCH TO BETTER UNDERSTAND THE MECHANISMS THAT DRIVE CANCER AND OTHER HUMAN DISEASES. INTEGRATING A VARIETY OF DISCIPLINES, OUR CLINICAL RESEARCHERS ARE CONTINUALLY DEVELOPING NEW THERAPEUTIC APPROACHES AND LEADING CLINICAL TRIALS THAT HELP MOVE DISCOVERIES FROM LABORATORY TO PATIENT. OUR PIONEERING RESEARCH HAS SAVED HUNDREDS OF THOUSANDS OF LIVES.
PUBLIC HEALTH SCIENCES DIVISION:THE PUBLIC HEALTH SCIENCES DIVISION IDENTIFIES STRATEGIES THAT WOULD ULTIMATELY REDUCE THE INCIDENCE OF AND MORTALITY FROM CANCER AND OTHER DISEASES. USING LARGE POPULATIONS AS THEIR "LABORATORY," OUR PUBLIC-HEALTH RESEARCHERS LOOK FOR LINKS BETWEEN CANCER AND ITS POSSIBLE TRIGGERS, FROM DIET AND LIFESTYLE TO ENVIRONMENTAL AND GENETIC FACTORS. IDENTIFYING SUCH CANCER CAUSES CAN LEAD TO BETTER CANCER-DETECTION METHODS AND NEW WAYS TO HELP PEOPLE ADOPT HEALTHIER LIFESTYLES TO MINIMIZE OR AVOID THEIR RISK OF GETTING THE DISEASE IN THE FIRST PLACE. OUR STATISTICAL, COMPUTATIONAL, EPIDEMIOLOGICAL, TRANSLATIONAL AND PREVENTION PROJECTS INCLUDE STUDIES AROUND THE WORLD.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Thomas James Lynch Jr President & Director | Officer | 40 | $1,702,109 |
Nancy E Davidson Sr. VP & Director, Crd | Officer | 8.4 | $1,266,466 |
Steve Stadum Spec Advisor | 40 | $1,132,208 | |
David Harlan Browdy VP & Chief Financial Officer | Officer | 40 | $853,047 |
Nicole C Robinson VP & Chief Operating Officer | Officer | 40 | $849,608 |
Eric C Holland Sr VP & Dir, Human Biology | Officer | 40 | $776,770 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Emmes Company Research Services | 3/30/22 | $4,535,807 |
University Of Washington Research Services | 3/30/22 | $4,029,022 |
Ellkay Llc Technology Services | 3/30/22 | $2,848,125 |
Ppd Development Research Services | 3/30/22 | $2,561,057 |
Norberto Zylberberg Marketing Services | 3/30/22 | $2,746,635 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $1,353,403 |
| Membership dues | $0 |
| Fundraising events | $4,198,103 |
| Related organizations | $0 |
| Government grants | $731,572,547 |
| All other contributions, gifts, grants, and similar amounts not included above | $42,538,990 |
| Noncash contributions included in lines 1a–1f | $11,364,583 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $779,663,043 |
| Total Program Service Revenue | $98,077,466 |
| Investment income | $13,075,022 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $5,514,448 |
| Net Rental Income | $3,905,117 |
| Net Gain/Loss on Asset Sales | $42,655,288 |
| Net Income from Fundraising Events | -$38,778 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $943,352,737 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $143,406,491 |
| Grants and other assistance to domestic individuals. | $1,843,911 |
| Grants and other assistance to Foreign Orgs/Individuals | $64,709,692 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $12,152,584 |
| Compensation of current officers, directors, key employees. | $7,283,437 |
| Compensation to disqualified persons | $168,938 |
| Other salaries and wages | $257,083,873 |
| Pension plan accruals and contributions | $20,038,938 |
| Other employee benefits | $27,931,333 |
| Payroll taxes | $21,672,281 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $1,521,423 |
| Fees for services: Accounting | $369,685 |
| Fees for services: Lobbying | $256,000 |
| Fees for services: Fundraising | $1,436,248 |
| Fees for services: Investment Management | $580,051 |
| Fees for services: Other | $66,194,816 |
| Advertising and promotion | $8,890,443 |
| Office expenses | $8,327,061 |
| Information technology | $17,789,520 |
| Royalties | $0 |
| Occupancy | $13,804,302 |
| Travel | $281,537 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $170,576 |
| Interest | $14,712,515 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $32,980,464 |
| Insurance | $3,447,436 |
| All other expenses | $9,666,395 |
| Total functional expenses | $829,721,537 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $900 |
| Savings and temporary cash investments | $34,992,371 |
| Pledges and grants receivable | $75,063,364 |
| Accounts receivable, net | $33,216,163 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $1,517,788 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $6,929,707 |
| Net Land, buildings, and equipment | $408,749,136 |
| Investments—publicly traded securities | $714,326,424 |
| Investments—other securities | $35,235,454 |
| Investments—program-related | $253,946,782 |
| Intangible assets | $2,537,571 |
| Other assets | $173,944,884 |
| Total assets | $1,740,460,544 |
| Accounts payable and accrued expenses | $71,905,974 |
| Grants payable | $0 |
| Deferred revenue | $44,614,965 |
| Tax-exempt bond liabilities | $394,418,977 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $158,030,059 |
| Total liabilities | $668,969,975 |
| Net assets without donor restrictions | $854,981,569 |
| Net assets with donor restrictions | $216,509,000 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $1,740,460,544 |
Grants Awarded
Over the last fiscal year, Fred Hutchinson Cancer Research Center has awarded $122,053,301 in support to 299 organizations.
| Grant Recipient | Amount |
|---|---|
UNIVERSITY OF WASHINGTON PURPOSE: VACCINE AND INFECTIOUS DISEASE | $20,142,359 |
ORLANDO IMMUNOLOGY CENTER PA PURPOSE: VACCINE AND INFECTIOUS DISEASE | $5,279,684 |
Seattle, WA PURPOSE: PUBLIC HEALTH SCIENCES | $4,699,154 |
Durham, NC PURPOSE: VACCINE AND INFECTIOUS DISEASE | $4,658,374 |
Somerville, MA PURPOSE: VACCINE AND INFECTIOUS DISEASE | $4,121,872 |
Lincoln, NE PURPOSE: VACCINE AND INFECTIOUS DISEASE | $3,746,490 |
Grants Recieved
Over the last fiscal year, we have identified 12 grants that Fred Hutchinson Cancer Research Center has recieved totaling $49,624.
| Awarding Organization | Amount |
|---|---|
Jackson S And March F Chao Foundation Seattle, WA PURPOSE: CANCER RESEARCH SUPPORT | $20,000 |
Kirchner Foundation Longview, WA PURPOSE: UNRESTRICTED | $7,500 |
Paul S Pariser Foundation Inc Oakville, WA PURPOSE: PASSOVER DONATIONS 2022 | $7,200 |
Hyman Levine Family Foundation Ldor Vdor Beverly Hills, CA PURPOSE: CHARITY/EDUCATION | $5,000 |
Youell Legacy Foundation Islamorada, FL PURPOSE: OPERATING EXPENSES | $4,000 |
The Kemper Freeman Foundation Bellevue, WA PURPOSE: GENERAL SUPPORT | $2,724 |
Endowment Analysis
| Beg. Balance | $598,070,707 |
| Earnings | -$13,380,016 |
| Admin Expense | $558,680,684 |
| Net Contributions | $9,300,000 |
| Other Expense | $35,310,007 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Fred Hutchinson Cancer Research Center Seattle, WA | $1,740,460,544 | $943,352,737 |
Cancer Research And Biostatistics Seattle, WA | $8,442,496 | $11,626,712 |
Rivkin Center For Ovarian Cancer Seattle, WA | $2,054,285 | $1,708,996 |
Cancer Ski Out Wilsonville, OR | $61,437 | $173,701 |
Ryan Hill Research Foundation Edmonds, WA | $2,849,969 | $249,913 |
Cush It To The Limit Sammamish, WA | $27,474 | $46,229 |
Treva Hoffman Foundation For Breast Cance Research And Patient Winchester, OR | $0 | $0 |
Cancer Cachexia Society Inc Issaquah, WA | $104,257 | $0 |
Prostate Cancer Treatment Center Foundation Edmonds, WA | $114,755 | $0 |
Betty Hise Trust For Cancer Research Salem, OR | $383,731 | $0 |
Janice Larsen Cancer Foundation Kirkland, WA | $208,833 | $21 |
Cure First Seattle, WA | $46,807 | $0 |